Pharmacytimes: Condition Center: HIV HIV en-us Sat, 24 Feb 2018 03:49:38 UTC Sat, 24 Feb 2018 03:49:38 UTC FDA: Antibiotic Commonly Taken by Patients with HIV May Increase CV Risk Clarithromycin (Biaxin) may increase the risk of heart problems and death among patients with cardiovascular disease.<br /> &nbsp; 4:52 PM, Thu February 22, 2018 FDA Tentatively OKs Fixed-Dose HIV Combo Therapy Under the PEPFAR program, the antiretroviral (ARV) combination will be available in developing countries as a treatment for patients with HIV/AIDS. 2:58 AM, Wed February 21, 2018 Opioids May Boost Pneumococcal Infection Risk A new study published in the Annals of Internal Medicine this week suggests that opioids may pose a different, unintended untoward consequence in patients: an increased risk of pneumococcal infection. 8:57 PM, Thu February 15, 2018 Pursuing Credentialing in HIV: Why? Why Not? As the job market for pharmacists becomes more competitive, many pharmacists are turning to credentialing as a way to distinguish themselves professionally.<br /> &nbsp; 1:17 PM, Wed February 14, 2018 Pharmacist-Administered ART Adherence Clinic Makes Inroads According to the US Department of Health and Human services, only 57% of people who receive an HIV diagnosis stay in HIV care.<br /> &nbsp; 3:40 PM, Thu February 8, 2018 FDA OKs 2 Fixed Dose HIV Treatments Officials with the FDA have approved 2 different fixed dose drugs indicated to treat HIV-1: Symfi Lo tablets&nbsp;and Biktarvy. 9:14 AM, Thu February 8, 2018 FDA Updates HIV Drug Label to Include Dosing for Pregnant Patients The FDA updated the labeling for rilipivirine (Edurant) for the treatment of HIV-positive pregnant patients who were on stable treatment prior to conception and who are virologically suppressed.&nbsp; 12:30 PM, Sat February 3, 2018 Dual Eligibility: Did Medication Reimbursement Changes Affect Adherence? The researchers concluded that this information has implications for all privatized, market-based prescription drug plans. 1:00 PM, Thu January 18, 2018 Could This Once-Weekly 'Pillbox' Capsule for HIV Replace Daily Dosing? Although substantial progress has been made in the advancement of HIV treatment and prevention, adherence remains a barrier for individuals taking medication on a frequent basis. 11:20 PM, Tue January 9, 2018 What Is the Optimal Age to Test for HIV? Many patients with HIV are unaware of their status, increasing risk for transmission of infection and leaving individuals susceptible to adverse events. For this reason, health advocates recommend that all individuals receive an HIV test.&nbsp; 11:12 AM, Tue January 9, 2018 Preexposure Prophylaxis: Get the Word Out! Oral preexposure prophylaxis (PrEP) has the potential to prevent HIV transmission and ultimately to help eradicate this devastating viral infection. 8:00 AM, Fri January 5, 2018 Aging with HIV: Comorbidities Increase Faster Than in Others What has changed in HIV over time? 10:30 AM, Wed January 3, 2018 A Pharmacist's Role in HIV Awareness With the growth in pharmacy over the past 10 years, pharmacists are now at the forefront of managing many more disease states than in the past. 11:12 PM, Mon January 1, 2018 4 Things Pharmacists Should Know About Rattlesnake Pills Rattlesnake pills have received media attention due to their link with Salmonella infection. 11:34 PM, Wed December 20, 2017 Perinatal HIV Infection: Nonadherence Risk Increases in Adolescents Adolescents and young adults who are living with HIV and were exposed to the virus perinatally have a unique risk of nonadherence in adolescence, as well as an elevated risk of mental health and substance use problems.&nbsp; 10:20 AM, Fri December 15, 2017 Twenty-One Million HIV Patients Now Have Access to Antiretroviral Therapy Nearly 21 million individuals with HIV had access to antiretroviral therapy (ART) in June 2017 compared to 685,000 HIV-positive patients in 2000.&nbsp; 10:47 AM, Fri December 1, 2017 Time to HIV Diagnosis Improving, But Many Still Unaware of Infection Status Americans are getting tested and diagnosed with HIV sooner after infection, according to a recently-published CDC <em>Vital Signs</em> report. 3:07 PM, Wed November 29, 2017 First Complete 2-Drug HIV Regimen Gets FDA OK Juluca is indicated as a complete therapy for patients with HIV-1.<br /> &nbsp; 3:12 PM, Tue November 21, 2017 Monitoring the Gut Microbiome in Patients with HIV &quot;Gut microbiome&quot; is becoming a buzzword in the health care community. 8:00 AM, Mon November 13, 2017 Antiretroviral Therapy for HIV: Pharmacogenetic Considerations Pharmacists can expect to see considerably more information about the implications of pharmacogenetics for drug treatment in every disease state. 10:09 AM, Wed November 1, 2017